64x
San Francisco, United States · Founded 2017 · $60.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $55.0M Series AJan 2022
- Rounds
- 2
About
Bioengineering platform enabling scalable manufacturing for next-generation gene therapies.
Summary
64x is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $60.0M in total across 2 rounds, most recently a $55.0M Series A round in Jan 2022. Investors include Lifeforce Capital, First Round Capital and Northpond Ventures.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2022
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/64x"><img src="https://indexed.vc/api/badge/company/64x" alt="64x on Indexed.vc" width="260" height="76" /></a>